BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23094864)

  • 1. Tanshinone derivatives: a patent review (January 2006 - September 2012).
    Tian XH; Wu JH
    Expert Opin Ther Pat; 2013 Jan; 23(1):19-29. PubMed ID: 23094864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone II-A: new perspectives for old remedies.
    Xu S; Liu P
    Expert Opin Ther Pat; 2013 Feb; 23(2):149-53. PubMed ID: 23231009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and SAR analysis of the cytotoxicity of tanshinones in colon cancer cells.
    Wang L; Liu A; Zhang FL; Yeung JH; Li XQ; Cho CH
    Chin J Nat Med; 2014 Mar; 12(3):167-71. PubMed ID: 24702801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress.
    Chen W; Tang F; Xie B; Chen S; Huang H; Liu P
    Eur J Pharmacol; 2012 Jan; 674(2-3):359-64. PubMed ID: 22088276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells.
    Jia LQ; Yang GL; Ren L; Chen WN; Feng JY; Cao Y; Zhang L; Li XT; Lei P
    J Ethnopharmacol; 2012 Aug; 143(1):100-8. PubMed ID: 22750433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress in the study of protective effect of tanshinone IIA on cerebral ischemic stroke].
    Li DC; Bao XQ; Sun H; Zhang D
    Yao Xue Xue Bao; 2015 Jun; 50(6):635-9. PubMed ID: 26521431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-target networks for Tanshinone IIA identified by data mining.
    Chen SJ
    Chin J Nat Med; 2015 Oct; 13(10):751-9. PubMed ID: 26481375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
    Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
    Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
    Yang X; Yan J; Feng J
    Eur J Pharmacol; 2016 Jan; 771():18-28. PubMed ID: 26683637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways.
    Wang X; Wang Y; Jiang M; Zhu Y; Hu L; Fan G; Wang Y; Li X; Gao X
    J Ethnopharmacol; 2011 Jun; 135(3):662-71. PubMed ID: 21497648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen.
    Fang J; Little PJ; Xu S
    Med Res Rev; 2018 Jan; 38(1):201-228. PubMed ID: 28295428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes.
    Zhou X; Wang Y; Or PM; Wan DC; Kwan YW; Yeung JH
    Phytomedicine; 2012 May; 19(7):648-57. PubMed ID: 22541637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in cardiovascular effects of tanshinone II(A)].
    Chen FY; Guo R; Zhang BK
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(9):1649-53. PubMed ID: 26323123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals.
    Lin TY; Lu CW; Huang SK; Wang SJ
    J Ethnopharmacol; 2013 May; 147(2):488-96. PubMed ID: 23542145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of tanshinone IIA pretreatment on IL-1β and RelA mRNA expression in rats with focal cerebral ischemia].
    Chen WY; Sun CM; Wang HM; Huang M; Zhu GX; Zhu BD; Liu FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2115-8. PubMed ID: 20855265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular actions and therapeutic potential of tanshinone IIA.
    Gao S; Liu Z; Li H; Little PJ; Liu P; Xu S
    Atherosclerosis; 2012 Jan; 220(1):3-10. PubMed ID: 21774934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation.
    Yang R; Liu A; Ma X; Li L; Su D; Liu J
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):396-401. PubMed ID: 18427283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
    Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
    Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalyst-Free sp
    Ding C; Li J; Jiao M; Zhang A
    J Nat Prod; 2016 Oct; 79(10):2514-2520. PubMed ID: 27672695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of spray drying process on physical properties and dissolution of tanshinone].
    Jiang YR; Zhang ZH; Ding DM; Yan HM; Sun E; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):817-20. PubMed ID: 25204171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.